Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Anheuser-Busch InBev SA/NV (ADR) (BUD) A Good Stock To Buy?

How do we determine whether Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows that their consensus long positions have historically outperformed the market when we adjust for known risk factors.

Is Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD) a buy here? Prominent investors are buying. The number of bullish hedge fund positions increased by 8 lately. BUD was in 49 hedge funds’ portfolios at the end of September. There were 41 hedge funds in our database with BUD positions at the end of the previous quarter. At the end of this article we will also compare BUD to other stocks including Bank of America Corp (NYSE:BAC), Nippon Telegraph & Telephone Corp (ADR) (NYSE:NTT), and Oracle Corporation (NASDAQ:ORCL) to get a better sense of its popularity.

Follow Anheuser Busch Inbev Sa Nv (NYSE:BUD)
Trade (NYSE:BUD) Now!

With all of this in mind, we’re going to check out the latest action surrounding Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD).

How are hedge funds trading Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD)?

At Q3’s end, a total of 49 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 20% from the previous quarter. With the smart money’s sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were boosting their stakes meaningfully (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Eric W. Mandelblatt’s Soroban Capital Partners has the number one equity position in Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD), worth close to $971.7 million, comprising 7.1% of its total 13F portfolio. Other members of the smart money that hold long positions comprise of Tom Russo’s Gardner Russo & Gardner, Ken Fisher’s Fisher Asset Management and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.